• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9600TFX29A
Medical Device Problem Code Perivalvular Leak (1457)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/15/2026
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The investigation is ongoing.
 
Event or Problem Description
As reported by the field clinical specialist (fcs), approximately 1 year and 8 months post transcatheter valve replacement procedure with a 29mm sapien 3 valve, the valve failed due to moderate-to-severe paravalvular leak (pvl) at the left cusp, as detected by transesophageal echocardiogram (tee).The physician requested an edwards representative be present for a re-dilation.The first dilation was a nominally prepped 29mm commander delivery system, and the pvl improved to moderate.After discussing with the operating team, the decision was made to add an additional 1ml to the balloon and post dilate again, but with concern for annular rupture.The post-dilation was performed successfully and the pvl had reduced to mild per tee.At this point, the team decided that they would stop rather than risk a rupture, considering the patient's age and calcium burden.It was noted that the patient had a known enlarged root previously and calcium at the left cusp, extending into the left ventricular outflow tract (lvot).Also, the pvl was present at initial implant and was trace at that time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE
Common Device Name
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key25125607
Report Number2015691-2026-15013
Device Sequence Number18307962
Product Code NPT
UDI-Device Identifier00690103194364
UDI-Public(01)00690103194364(17)270101
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
P140031
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 06/23/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date01/01/2017
Device Model Number9600TFX29A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/15/2026
Supplement Date Received by Manufacturer06/09/2026
Initial Report FDA Received Date05/08/2026
Supplement Report FDA Received Date06/23/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured01/02/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-